Related Experiment Video
Updated: Apr 25, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants
Shunsuke Araki1, Shutaro Suga1, Fuyu Miyake1
1Department of Pediatrics, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan; Center of Maternal, Fetal and Neonatal Medicine, University of Occupational and Environmental Health Hospital, Kitakyushu, Japan.
Insights
Neonatal serum PCSK9 levels differ by gender and correlate with LDL-C. This suggests Protein convertase subtilisin/Kexin type-9 (PCSK9) influences fetal lipoprotein regulation.
Area of Science:
- Neonatal physiology
- Lipid metabolism
- Endocrinology
Background:
- Protein convertase subtilisin/Kexin type-9 (PCSK9) is crucial in lipoprotein metabolism.
- Its role during the fetal period remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of PCSK9 in regulating lipoproteins during fetal development.
- To quantify neonatal serum PCSK9 levels and their associations.
Main Methods:
- Cross-sectional study of 81 neonates.
- Serum PCSK9 levels measured using ELISA kits.
- Analysis of correlations with cholesterol, birth weight, and gestational age.
Main Results:
- Median PCSK9 concentration was lower in males than females (p<0.001).
- PCSK9 levels positively correlated with total cholesterol and LDL-C (p<0.05).
- PCSK9 and gestational age independently predicted serum LDL-C.
Conclusions:
- First quantitative analysis of neonatal serum PCSK9.
- Circulating PCSK9 levels exhibit gender-based differences at birth.
- PCSK9 may play a significant role in fetal LDL-C regulation.
Background And Aims:
Protein convertase subtilisin/Kexin type-9 (PCSK9) is a substantial player in lipoprotein metabolism. This study was designed to elucidate the role of PCSK9 in the regulation of lipoprotein during the fetal period.
Study Design And Subjects:
This study was a cross-sectional study. Eighty-one neonates (45 males, 36 females) who were admitted to the neonatal intensive care unit were enrolled in the study. The median age in gestational weeks and weight at birth were 37.1 weeks and 2493 g, respectively. There were no gender differences, but the proportion of infants who were small-for-gestational age (SGA) was significantly higher among females than males. The prefed serum PCSK9 level was assayed with ELISA kits.
Results:
The median PCSK9 concentration in male newborns was significantly lower than that in females (148.2 ng/ml vs. 171.4 ng/ml, respectively, p<0.001). Circulating serum PCSK9 levels were positively correlated with total cholesterol (r=0.281, p<0.05) and low-density lipoprotein cholesterol (LDL-C; r=0.272, p<0.05). However, there were no correlations between PCSK9 levels and birth weight, gestational age or SGA. Multivariate forward stepwise linear regression analysis revealed that gestational age and circulating PCSK9 levels were independent predictors of the serum LDL-C levels in newborn infants.
Conclusion:
Our first quantitative analysis of neonatal serum PCSK9 levels at birth showed that circulating PCSK9 levels show gender-based differences and are significantly correlated with LDL-C. These results suggest that PCSK9 could play an important role in regulating LDL-C levels during the fetal period.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Cholesterol: Significance and Regulation
Considering cholesterol and...
Coronary Artery Disease IV: Preventive Measures
Lipids: Dietary Sources and Requirements

